ConductScience.org, home

Trial · NCT00301262

Outcomes49

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYErectile Dysfunction Inventory of Treatment Satisfaction (EDITS) Index at the End of the DB Treatment (Week 8)Week 8number of subjects in the Full Analysis Set (FAS) population with an observationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYErectile Dysfunction Inventory of Treatment Satisfaction (EDITS) IndexWeek 8, Week 14number of subjects in the FAS population with an observationscores on a scaleMEAN
SECONDARYChange From Baseline to End of Double-Blind Phase (Week 8) in Patient Reported Erectile Function Assessment (PREFA) Total ScoreWeek 8number of subjects in the FAS population with an observationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYPatient Reported Erectile Function Assessment (PREFA) Total ScoreWeek 8, Week 14number of subjects in the FAS population with an observationscores on a scaleMEAN
SECONDARYChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Erectile FunctionWeek 8number of subjects in the FAS population with an observationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Orgasmic FunctionWeek 8number of subjects in the FAS population with an observationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Sexual DesireWeek 8number of subjects in the FAS population with an observationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Intercourse SatisfactionWeek 8number of subjects in the FAS population with an observationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYChange From Baseline to End of DB Phase (Week 8) in International Index of Erectile Function (IIEF) Domain Scores- Overall SatisfactionWeek 8number of subjects in the FAS population with an observationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYInternational Index of Erectile Function (IIEF) Domain Scores- Erectile FunctionWeek 8, Week 14number of subjects in the FAS population with an observationscores on a scaleMEAN
SECONDARYInternational Index of Erectile Function (IIEF) Domain Scores- Orgasmic FunctionWeek 8, Week 14number of subjects in the FAS population with an observationscores on a scaleMEAN
SECONDARYInternational Index of Erectile Function (IIEF) Domain Scores- Sexual DesireWeek 8, Week 14number of subjects in the FAS population with an observationscores on a scaleMEAN
SECONDARYInternational Index of Erectile Function (IIEF) Domain Scores- Intercourse SatisfactionWeek 8, Week 14number of subjects in the FAS population with an observationscores on a scaleMEAN
SECONDARYInternational Index of Erectile Function (IIEF) Domain Scores- Overall SatisfactionWeek 8, Week 14number of subjects in the FAS population with an observationscores on a scaleMEAN
SECONDARYChange From Baseline to End of DB Phase (Week 8) in Erectile Distress Scale (EDS) Total ScoreWeek 8number of subjects in the FAS population with an observationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYErectile Distress Scale (EDS) Total ScoreWeek 8, Week 14number of subjects in the FAS population with an observationscores on a scaleMEAN
SECONDARYChange From Baseline to End of DB Phase (Week 8) in Quality of Erection Questionnaire (QEQ) Total ScoreWeek 8number of subjects in the FAS population with an observationscores on a scaleLEAST_SQUARES_MEAN
SECONDARYQuality of Erection Questionnaire (QEQ) Total ScoreWeek 8, Week 14Full Analysis Setscores on a scaleMEAN
SECONDARYGlobal Efficacy Question 1 (GEQ1) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)Week 8, Week 14number of subjects in the FAS population with an observationpercentage of subjectsNUMBER
SECONDARYGlobal Efficacy Question 2 (GEQ2) Response at End of the Double-Blind Phase (Week 8) and at End of the Open-Label Phase (Week 14)Week 8, Week 14number of subjects in the FAS population with an observationpercentage of subjectsNUMBER

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00301262/outcomes